Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
NCT04428073
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID
Interventions
BIOLOGICAL:
Covax-19™
Sponsor
GeneCure Biotechnologies